Literature DB >> 7988557

Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes.

C Beadling1, D Guschin, B A Witthuhn, A Ziemiecki, J N Ihle, I M Kerr, D A Cantrell.   

Abstract

The activation of Janus protein tyrosine kinases (JAKs) and signal transducer and activator of transcription (STAT) proteins by interleukin (IL)-2, the T cell antigen receptor (TCR) and interferon (IFN) alpha was explored in human peripheral blood-derived T cells and the leukemic T cell line Kit225. An IL-2-induced increase in JAK1 and JAK3, but not JAK2 or Tyk2, tyrosine phosphorylation was observed. In contrast, no induction of tyrosine phosphorylation of JAKs was detected upon stimulation of the TCR. IFN alpha induced the tyrosine phosphorylation of JAK1 and Tyk2, but not JAK2 or JAK3. IFN alpha activated STAT1, STAT2 and STAT3 in T cells, but no detectable activation of these STATs was induced by IL-2. However, IL-2 regulates the DNA binding and tyrosine phosphorylation of two STAT-like protein complexes which do not include STAT1, STAT2 or STAT3. STAT4 is not activated by IL-2. The activation of STAT5 cannot be excluded, so the IL-2-activated complexes most probably include at least one novel STAT. No STAT activity was detected in TCR-stimulated lymphocytes, indicating that the JAK/STAT pathway defined in this study constitutes an IL-2R-mediated signaling event which is not shared by the TCR. Finally, in other cell types the correlation between JAK1 activation and the induction of STAT1 has suggested that JAK1 may activate STAT1. The observation that IL-2 and IFN alpha activate JAK1 to a comparable degree, but only IFN alpha activates STAT1, indicates that JAK1 activation is not the only determining factor for STAT1 activation. Moreover, the data show that JAK1 stimulation is also not sufficient for STAT3 activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988557      PMCID: PMC395525          DOI: 10.1002/j.1460-2075.1994.tb06898.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  77 in total

1.  ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains.

Authors:  X Y Fu; D S Kessler; S A Veals; D E Levy; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 3.  A new cytokine receptor superfamily.

Authors:  D Cosman; S D Lyman; R L Idzerda; M P Beckmann; L S Park; R G Goodwin; C J March
Journal:  Trends Biochem Sci       Date:  1990-07       Impact factor: 13.807

4.  The interleukin-2 T-cell system: a new cell growth model.

Authors:  D A Cantrell; K A Smith
Journal:  Science       Date:  1984-06-22       Impact factor: 47.728

5.  Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus.

Authors:  T Hori; T Uchiyama; M Tsudo; H Umadome; H Ohno; S Fukuhara; K Kita; H Uchino
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

6.  Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator.

Authors:  D S Kessler; S A Veals; X Y Fu; D E Levy
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

7.  Identification and chromosomal mapping of new human tyrosine kinase genes.

Authors:  J J Krolewski; R Lee; R Eddy; T B Shows; R Dalla-Favera
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

8.  A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization.

Authors:  M Hatakeyama; H Mori; T Doi; T Taniguchi
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

9.  Interleukin-2 induction of T-cell G1 progression and c-myb expression.

Authors:  J B Stern; K A Smith
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

Review 10.  Interleukin-2: inception, impact, and implications.

Authors:  K A Smith
Journal:  Science       Date:  1988-05-27       Impact factor: 47.728

View more
  52 in total

1.  Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.

Authors:  Q Zhang; P N Raghunath; E Vonderheid; N Odum; M A Wasik
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Following the cytokine signaling pathway to leukemogenesis: a chronology.

Authors:  Kendall A Smith; James D Griffin
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

3.  Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation.

Authors:  Y J Zhou; K S Magnuson; T P Cheng; M Gadina; D M Frucht; J Galon; F Candotti; R L Geahlen; P S Changelian; J J O'Shea
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 4.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

5.  Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins.

Authors:  M L Vignais; H B Sadowski; D Watling; N C Rogers; M Gilman
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 6.  Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Authors:  J J O'Shea; L D Notarangelo; J A Johnston; F Candotti
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

7.  Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).

Authors:  M Nielsen; A Svejgaard; C Röpke; M Nordahl; N Odum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity.

Authors:  S L Gaffen; S Y Lai; W Xu; F Gouilleux; B Groner; M A Goldsmith; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  Lipogenesis impaired in periparturient rats exposed to altered gravity is independent of prolactin and glucocorticoid secretion.

Authors:  Osman V Patel; Elzbieta Zakrzewska; Rhonda L Maple; Lisa A Baer; April E Ronca; Charles E Wade; Karen Plaut
Journal:  Eur J Appl Physiol       Date:  2008-07-30       Impact factor: 3.078

Review 10.  IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cells.

Authors:  K S Zier; B Gansbacher
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.